Alliancebernstein L.P. Abb Vie Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Abb Vie Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 4,924,388 shares of ABBV stock, worth $835 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

4,924,388

Previous 4,734,301 4.02%

Holding current value

$835 Million

Previous $812 Million 19.76%

% of portfolio

0.34%

Previous 0.29%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $31.1 Million - $37.9 Million	190,087 Added 4.02%	4,924,388 $972 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $24.9 Million - $29.1 Million	-160,901 Reduced 3.29%	4,734,301 $812 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $112 Million - $128 Million	701,455 Added 16.73%	4,895,202 $891 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $12 Million - $13.5 Million	86,936 Added 2.12%	4,193,747 $650 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $23.3 Million - $27 Million	-174,299 Reduced 4.07%	4,106,811 $612 Million
Q2 2023 Aug 15, 2023	BUY	$132.51 - $164.9 $38.1 Million - $47.4 Million	287,276 Added 7.19%	4,281,110 $577 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $592,467 - $682,314	4,097 Added 0.1%	3,993,834 $636 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $16 Million - $19.1 Million	115,439 Added 2.98%	3,989,737 $645 Million
Q3 2022 Nov 15, 2022	SELL	$134.21 - $153.93 $1.01 Million - $1.16 Million	-7,540 Reduced 0.19%	3,874,298 $520 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $45.5 Million - $57.8 Million	330,490 Added 9.31%	3,881,838 $595 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $56.9 Million - $70.5 Million	430,787 Added 13.8%	3,551,348 $576 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $29.5 Million - $37.4 Million	275,034 Added 9.67%	3,120,561 $423 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $34.8 Million - $39.5 Million	327,105 Added 12.99%	2,845,527 $307 Million
Q2 2021 Jul 30, 2021	SELL	$105.21 - $117.21 $22.4 Million - $25 Million	-212,935 Reduced 7.8%	2,518,422 $284 Million
Q1 2021 May 06, 2021	SELL	$102.3 - $112.62 $30.6 Million - $33.7 Million	-299,518 Reduced 9.88%	2,731,357 $296 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $8.51 Million - $11.5 Million	105,761 Added 3.62%	3,030,875 $325 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $274,654 - $322,353	-3,197 Reduced 0.11%	2,925,114 $256 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $23.8 Million - $31.9 Million	325,062 Added 12.49%	2,928,311 $288 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $2.8 Million - $4.25 Million	-43,458 Reduced 1.64%	2,603,249 $198 Million
Q4 2019 Feb 18, 2020	SELL	$72.13 - $90.25 $19.3 Million - $24.2 Million	-267,988 Reduced 9.19%	2,646,707 $234 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $3.97 Million - $4.78 Million	63,064 Added 2.21%	2,914,695 $221 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $4.84 Million - $6.18 Million	73,647 Added 2.65%	2,851,631 $207 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $7.78 Million - $9.16 Million	-100,845 Reduced 3.5%	2,777,984 $224 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $4.18 Million - $5.15 Million	-53,638 Reduced 1.83%	2,878,829 $265 Million
Q3 2018 Nov 08, 2018	SELL	$88.91 - $98.84 $64.6 Million - $71.8 Million	-726,236 Reduced 19.85%	2,932,467 $277 Million
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $20.5 Million - $24.2 Million	-228,235 Reduced 5.87%	3,658,703 $339 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $130 Million - $175 Million	-1,417,376 Reduced 26.72%	3,886,938 $368 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $14.7 Million - $16.1 Million	-163,683 Reduced 2.99%	5,304,314 $513 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $382 Million - $488 Million	5,467,997	5,467,997 $486 Million

Others Institutions Holding ABBV

# of Institutions

3,837

Shares Held

1.25B

Call Options Held

15.7M

Put Options Held

11.3M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Abb Vie Inc. Transaction History